Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Description
ePharmacy involves the sale and delivery of prescription drugs, over-the-counter medications, health and wellness products, and other related items through digital platforms, websites, and mobile applications. ePharmacies provide a convenient and accessible way for consumers to purchase medications and healthcare products. They can browse and order products from the comfort of their homes, eliminating the need to visit physical pharmacies or stores.
The epharmacy market in Europe is projected to rise by USD 13.7 billion by 2029, according to the latest market study results. It is anticipated to expand at a CAGR of 14.15 percent during the forecast period.
The report covers market size and growth, segmentation, country breakdowns, competitive landscape, trends and strategies for epharmacy market in Europe. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors' approaches.
Market Segmentation
Type: prescription, over the counter (OTC)
Product: chronic drugs, acute drugs, nutrition, dermo cosmetics, personal care, others
Operating platform: website, apps
Country: Germany, France, UK, Spain, Italy, Norway, Czech, Rest of Europe
This industry report offers market estimates and forecasts of the Europe market, followed by a detailed analysis of the type, product, operating platform, and country. The Europe market for epharmacy can be segmented by type: prescription, over the counter (OTC). In 2022, the over the counter (OTC) segment made up the largest share of revenue generated by the epharmacy market. Epharmacy market is further segmented by product: chronic drugs, acute drugs, nutrition, dermo cosmetics, personal care, others. The dermo cosmetics segment was the largest contributor to the Europe epharmacy market in 2022. Based on operating platform, the epharmacy market is segmented into: website, apps. The website segment is estimated to account for the largest share of the epharmacy market in Europe. On the basis of country, the epharmacy market also can be divided into: Germany, France, UK, Spain, Italy, Norway, Czech, Rest of Europe. Germany held the largest share of the Europe epharmacy market in 2022 and is anticipated to hold its share during the forecast period.
Major Companies and Competitive Landscape
The report explores the recent developments and profiles of key vendors in the ePharmacy Market in Europe, including Apoteket AB, Bestway Group Limited, DocMorris AG, Index Medical Ltd., Lloyds Pharmacy Ltd., medpex wholesale GmbH, Pears Health Cyber, s.r.o., Redcare Pharmacy NV, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Scope of the Report
To analyze and forecast the market size of the epharmacy market in Europe.
To classify and forecast the epharmacy market in Europe based on type, product, operating platform, country.
To identify drivers and challenges for the epharmacy market in Europe.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the epharmacy market in Europe.
To identify and analyze the profile of leading players operating in the epharmacy market in Europe.
Why Choose This Report
Gain a reliable outlook of the epharmacy market in Europe forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.